We need a smarter way to discover drugs
Every patient’s tumor is different and changes all the time
Response rates of patients to even the
most targeted drugs
is 30% at best
Traditional models of discovery are poorly predictive of patient response
Every patient’s tumor is different and changes all the time
Response rates of patients to even the
most targeted drugs
is 30% at best
Traditional models of discovery are poorly predictive of patient response